I agree that this site is using cookies. You can find further informations here.
X
Stuurman, Anke L.
64  results:
Search for persons X
?
1

COVID-19 vaccine booster doses provide increased protection..:

Meeraus, Wilhelmine ; Stuurman, Anke L. ; Durukal, Ilgaz...
Vaccine.  41 (2023)  42 - p. 6366-6378 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Brand-specific estimates of influenza vaccine effectiveness..:

Stuurman, Anke L. ; Carmona, Antonio ; Biccler, Jorne...
Frontiers in Public Health.  11 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
3

Protection against COVID-19 hospitalisation conferred by pr..:

Meeraus, Wilhelmine ; de Munter, Leonie ; Gray, Christen M....
The Lancet Regional Health - Europe.  31 (2023)  - p. 100675 , 2023
Link: https://doi.org/10.1016/..
 
?
4

The value of public-private collaborative real-world eviden..:

Díez-Domingo, Javier ; Torcel-Pagnon, Laurence ; Carmona, Antonio...
Expert Review of Vaccines.  21 (2022)  12 - p. 1701-1710 , 2022
Link: https://doi.org/10.1080/..
 
?
5

Investigating confounding in network‐based test‐negative de..:

Stuurman, Anke L. ; Levi, Miriam ; Beutels, Philippe...
Influenza and Other Respiratory Viruses.  17 (2022)  1 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
6

Operational lessons learned in conducting an international ..:

Sharan, Apoorva ; Jahagirdar, Shubhashri ; Stuurman, Anke L...
Vaccine: X.  11 (2022)  - p. 100160 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Estimating baseline rates of adverse perinatal and neonatal..:

Sharan, Apoorva ; Stuurman, Anke L. ; Jahagirdar, Shubhashri...
eClinicalMedicine.  50 (2022)  - p. 101506 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Brand-specific influenza vaccine effectiveness estimates du..:

Stuurman, Anke L. ; Biccler, Jorne ; Carmona, Antonio...
Vaccine.  39 (2021)  29 - p. 3964-3973 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Investigating the procurement system for understanding seas..:

Stuurman, Anke L. ; Rizzo, Caterina ; Haag, Mendel.
PLOS ONE.  16 (2021)  4 - p. e0248943 , 2021
Link: https://doi.org/10.1371/..
 
?
10

WHO global vaccine safety multi-country collaboration proje..:

Stuurman, Anke L. ; Sharan, Apoorva ; Jahagirdar, Shubhashri...
Vaccine: X.  9 (2021)  - p. 100123 , 2021
Link: https://doi.org/10.1016/..
 
?
11

Factors driving choices between types and brands of influen..:

Stuurman, Anke L. ; Ciampini, Sara ; Vannacci, Alfredo...
PLOS ONE.  16 (2021)  6 - p. e0252836 , 2021
Link: https://doi.org/10.1371/..
 
?
12

Challenges and Adaptation of a European Influenza Vaccine E..:

Carmona, Antonio ; Muñoz-Quiles, Cintia ; Stuurman, Anke...
International Journal of Environmental Research and Public Health.  18 (2021)  3 - p. 1058 , 2021
Link: https://doi.org/10.3390/..
 
?
13

Vaccine effectiveness against laboratory-confirmed influenz..:

Stuurman, Anke L. ; Bollaerts, Kaatje ; Alexandridou, Maria...
Vaccine.  38 (2020)  41 - p. 6455-6463 , 2020
Link: https://doi.org/10.1016/..
 
?
14

Vaccine safety surveillance in pregnancy in low- and middle..:

Stuurman, Anke L. ; Riera, Margarita ; Lamprianou, Smaragda...
Vaccine.  36 (2018)  45 - p. 6736-6743 , 2018
Link: https://doi.org/10.1016/..
 
?
15

Effectiveness of pneumococcal vaccines in preventing pneumo..:

Tin Tin Htar, Myint ; Stuurman, Anke L. ; Ferreira, Germano...
PLOS ONE.  12 (2017)  5 - p. e0177985 , 2017
Link: https://doi.org/10.1371/..
 
1-15